Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE) is pleased to announce the appointment of experienced Chief Financial Officer, Mr Tony Di Pietro. Tony will also be appointed as Company Secretary upon his arrival.
Mr Di Pietro is a Chartered Accountant and an Associate of the Governance Institute Australia with 18 years
Biotechnology industry experience.
Needham Maintains Buy on Alphatec Holdings, Raises Price Target to $14
Needham analyst David Saxon maintains Alphatec Holdings (NASDAQ:ATEC) with a Buy and raises the price target from $13 to $14.
